Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing

被引:12
|
作者
Pujol, Nina [1 ]
Heeke, Simon [2 ]
Bontoux, Christophe [3 ,4 ]
Boutros, Jacques [4 ,5 ]
Ilie, Marius [3 ,4 ]
Hofman, Veronique [3 ,4 ]
Marquette, Charles-Hugo [4 ,5 ]
Hofman, Paul [3 ,4 ]
Benzaquen, Jonathan [4 ,5 ]
机构
[1] Cote dAzur Univ, Ctr Antoine Lacassagne, Dept Radiat Oncol, F-06000 Nice, France
[2] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[3] Cote dAzur Univ, Ctr Hosp Univ Nice, Lab Clin & Expt Pathol, Pasteur Hosp 1,FHU OncoAge, Biobank BB 0033 00025, F-06000 Nice, France
[4] Cote dAzur Univ, Inst Res Canc & Aging, INSERM U1081, CNRS,UMR 7284, F-06000 Nice, France
[5] Cote dAzur Univ, Ctr Hosp Univ Nice, Dept Pulm Med & Thorac Oncol, FHU OncoAge,Pasteur Hosp 1, F-06000 Nice, France
来源
JOURNAL OF PERSONALIZED MEDICINE | 2022年 / 12卷 / 10期
关键词
next-generation sequencing; predictive biomarker; non-small cell lung carcinoma; precision oncology; OPEN-LABEL; TARGETED THERAPY; CANCER PATIENTS; SOLID TUMORS; FUSION; MUTATION; IMMUNOHISTOCHEMISTRY; GENE; CHEMOTHERAPY; DRIVER;
D O I
10.3390/jpm12101684
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Molecular diagnosis of lung cancer is a constantly evolving field thanks to major advances in precision oncology. The wide range of actionable molecular alterations in non-squamous non-small cell lung carcinoma (NS-NSCLC) and the multiplicity of mechanisms of resistance to treatment resulted in the need for repeated testing to establish an accurate molecular diagnosis, as well as to track disease evolution over time. While assessing the increasing complexity of the molecular composition of tumors at baseline, as well as over time, has become increasingly challenging, the emergence and implementation of next-generation sequencing (NGS) testing has extensively facilitated molecular profiling in NS-NSCLC. In this review, we discuss recent developments in the molecular profiling of NS-NSCLC and how NGS addresses current needs, as well as how it can be implemented to address future challenges in the management of NS-NSCLC.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Potential Impact of KRAS Molecular Profiling of Non-Squamous Non-Small Cell Lung Cancer (NSCLC).
    Karim, N.
    Pathrose, J.
    Fathallah, H.
    El Desouki, I.
    Perry, A.
    Starnes, S.
    Morris, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S714 - S715
  • [22] Next-Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Yields More Actionable Alterations
    Mehrad, Mitra
    Roy, Somak
    Bittar, Humberto Trejo
    Dacic, Sanja
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (03) : 353 - 357
  • [23] MOLECULAR TESTING IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER AND THE ROLE OF LIQUID CYTOLOGY SPECIMENS
    Moore, S.
    Loff, K.
    Murphy, M.
    RESPIROLOGY, 2020, 25 : 60 - 60
  • [24] Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non-Small Cell Lung Cancer
    Yu, Tiffany M.
    Morrison, Carl
    Gold, Edward J.
    Tradonsky, Alison
    Arnold, Renee J. G.
    VALUE IN HEALTH, 2018, 21 (11) : 1278 - 1285
  • [25] Therapeutic strategy for non-small cell lung cancer in the next-generation sequencing era
    Hayashi, Ryuji
    RESPIRATORY INVESTIGATION, 2021, 59 (01) : 1 - 2
  • [26] Clinical applications of a next-generation sequencing panel in non-small cell lung cancer
    Rijavec, E.
    Genova, C.
    Barletta, G.
    Biello, F.
    Maggioni, C.
    Dal Bello, M. G.
    Truini, A.
    Coco, S.
    Vanni, I.
    Alama, A.
    Grossi, F.
    ANNALS OF ONCOLOGY, 2015, 26 : 86 - 87
  • [27] Atezolizumab in non-squamous non-small cell lung cancer
    Akamine, Takaki
    Toyokawa, Gouji
    Tagawa, Tetsuzo
    Seto, Takashi
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S3155 - S3159
  • [28] Setting Up an Ultra-Fast Next-Generation Sequencing Approach as a Reflex Testing at Diagnosis in Nonsquamous Non-small Cell Lung Cancer
    Bontoux, C.
    Heeke, S.
    Hofman, V.
    Lespinet-Fabre, V.
    Bordone, O.
    Lassalle, S.
    Long-Mira, E.
    Lalvee, S.
    Tanga, V.
    Allegra, M.
    Salah, M.
    Benzaquen, J.
    Marquette, C. -H.
    Ilie, M.
    Hofman, P.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S511 - S511
  • [29] Next-generation sequencing discordant ALK-rearrangement in non-small cell lung carcinoma with ovarian metastases
    Tan, Charles Jeffrey Lay
    Li, Rubi K.
    ANNALS OF ONCOLOGY, 2023, 34 : S1460 - S1460
  • [30] Molecular testing in older patients treated for an advanced or metastatic non-squamous non-small cell lung cancer
    Lamy, T.
    Cabarrou, B.
    Planchard, D.
    Quantin, X.
    Schneider, S.
    Bringuier, M.
    Besse, B.
    Perol, M.
    Girard, N.
    Schott, R.
    Chouaid, C.
    Ricordel, C.
    Gervais, R.
    Debieuvre, D.
    Audigier-Valette, C.
    Carton, M.
    Filleron, T.
    Simon, G.
    Robain, M.
    Baldini, C.
    ANNALS OF ONCOLOGY, 2021, 32 : S1243 - S1244